# Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)

> **NCT06141369** · NA · RECRUITING · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 21 (estimated)

## Conditions studied

- Adrenal Cortical Carcinoma
- Medullary Thyroid Cancer
- Thymic Neuroendocrine Carcinoma
- Pancreatic Neuroendocrine Tumor

## Interventions

- **BIOLOGICAL:** individualized mRNA neoantigen vaccine (mRNA-0523-L001)

## Key facts

- **NCT ID:** NCT06141369
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-13
- **Primary completion:** 2026-12-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2026-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06141369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06141369, "Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT06141369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*